Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/20/2008US20080286280 Stable Lyophilized Pharmaceutical Preparations of Monoclonal or polyclonal antibodies
11/20/2008US20080286279 Treatment of Severe Community-Acquired Pneumonia by Administration of Tissue Factor Pathway Inhibitor (Tfpi)
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286271 Methods and Compositions for Modulating Tweak and Fn14 Activity
11/20/2008US20080286268 Processed ecm materials with enhanced component profiles
11/20/2008US20080286264 Modulation of Muc1 Activity
11/20/2008US20080286261 Methods of modulating hair growth
11/20/2008US20080286260 Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)
11/20/2008US20080286259 Use of activated coagulation factor vii for treating thrombolytic therapy-induced major bleedings
11/20/2008US20080286258 Bifeprunox mesylate maintenance dose compositions and methods for using the same
11/20/2008US20080286257 Compounds for Use in Treating Abnormal Cell Proliferation, and Methods of Producing Same
11/20/2008US20080286255 Treatment for eye disorder
11/20/2008US20080286253 Composition Comprising Polymeric Material And Uses Thereof
11/20/2008US20080286248 Hiv Vif Mutants
11/20/2008US20080286247 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
11/20/2008US20080286239 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/20/2008US20080286234 Method for treating demyelinating diseases
11/20/2008US20080286233 Piperizinyl macrocyclic hepatitis c serine protease inhibitors
11/20/2008US20080286232 Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione
11/20/2008US20080286231 Novel inhibitors of glutaminyl cyclase
11/20/2008US20080286230 Compounds and pharmaceutical compositions for the treatment of viral infections
11/20/2008US20080286229 Method to promote hair growth and/or delay or treat hair loss by administering a tgf-beta antagonist or inhibitor
11/20/2008US20080286228 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
11/20/2008US20080286227 Use of Il-17F for the Treatment and/or Prevention of Neurologic Diseases
11/20/2008US20080286211 Treating pain associated with epithelial lesions and disorders of impaired mucin function using a pharmaceutical composition containing mucin glycoproteins in combination with therapeutic agents, e.g., trefoil polypeptides
11/20/2008US20080286210 Novel antimicrobial peptides
11/20/2008US20080286205 Method for Treating Prostate Diseases Based on Local Delivery of Active Substances
11/20/2008US20080286201 Caspase-3 Substrate Comprising Imaging Agents
11/20/2008DE102007024239A1 Angiogenese förderndes Substrat Angiogenesis-promoting substrate
11/20/2008CA2705612A1 Radiation protection and treatment for exposure to gamma-radiation
11/20/2008CA2687269A1 Compositions for protein delivery and methods of use thereof
11/20/2008CA2687254A1 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
11/20/2008CA2687079A1 Methods of treatment of skin ulcers
11/20/2008CA2687001A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008CA2686997A1 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686994A1 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008CA2686895A1 Synthetic peptide materials for joint reconstruction, repair and cushioning
11/20/2008CA2686216A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
11/20/2008CA2685769A1 Use of the augmenter of liver regeneration protein as an apoptosis regulator
11/20/2008CA2685551A1 Anti-tumor drug, medicament, composition, and use thereof
11/20/2008CA2685380A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008CA2684557A1 New cyclic peptide compounds
11/20/2008CA2675992A1 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
11/20/2008CA2671133A1 Peptide nanoparticles and uses therefor
11/20/2008CA2670320A1 Modulation of rhamm (cd168) for selective adipose tissue development
11/20/2008CA2670014A1 Production of anti-microbial peptides
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992694A1 Anti-tumor drug, medicament, composition, and use thereof
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1992642A1 Collagen fibrils carrying bioactive heterologous domains and their use in e.g. wound healing
11/19/2008EP1992641A2 GLP-1 analogues
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992639A1 Peptide vaccine for inducing production of anti-amyloid- -peptide antibody
11/19/2008EP1992638A1 Immunomodulatory and anti-tumour peptides
11/19/2008EP1992637A1 1-Aminocyclopentane-1,3,4- tricarboxylic acids derivatives
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1992633A1 VEGI, an inhibitor of angiogenesis and tumor growth
11/19/2008EP1992360A1 Joint use of tgf-beta signal inhibitor and antitumor agent
11/19/2008EP1992359A1 Neurotropic virus transport
11/19/2008EP1992357A1 Botulinum toxin treatments of neurological and neuropsychiatric disorders
11/19/2008EP1992356A2 Rapamycin and IL-10 for the treatment of immune diseases
11/19/2008EP1992355A1 Pharmaceutical combination medication comprising NSAIDs or cytoxic drugs
11/19/2008EP1992354A1 Rheumatoid arthritis-preventive agent for oral intake
11/19/2008EP1992353A1 Vasodilator
11/19/2008EP1992352A1 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
11/19/2008EP1991874A2 Diagnostic kits to detect sp22 and sp22 antibodies
11/19/2008EP1991679A2 Human interferon-gamma (ifngamma) variants
11/19/2008EP1991589A1 Method for enhancing cyclodextrin complexation
11/19/2008EP1991576A1 Insulin derivatives
11/19/2008EP1991575A1 Single-chain insulin analogues and pharmaceutical formulations thereof
11/19/2008EP1991574A2 Oxyntomodulin derivatives
11/19/2008EP1991561A2 Branched multimeric peptides for tumor diagnosis and therapy
11/19/2008EP1991282A2 Compositions and methods for treating bone
11/19/2008EP1991258A2 Collagenase for treating cellulite
11/19/2008EP1991257A1 Highly phosphorylated and sulfated recombinant factor ix
11/19/2008EP1991255A1 Coagulation factor x polypeptides with modified activation properties
11/19/2008EP1991254A2 Broad spectrum immune and antiviral gene modulation by oral interferon
11/19/2008EP1991253A2 Nerve regeneration employing keratin biomaterials
11/19/2008EP1991252A2 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor
11/19/2008EP1991251A1 Use of tlr3 agonists for the treatment of neurodegenerative disorders
11/19/2008EP1991250A2 Methods for regulating inflammatory mediators and peptides useful therein
11/19/2008EP1991249A2 Treatment with cyclosporin a
11/19/2008EP1991247A1 Bifunctional histone deacetylase inhibitors
11/19/2008EP1991246A2 Treatment of development-related disorders
11/19/2008EP1893187B1 Improved antimicrobial peroxidase compositions
11/19/2008EP1809264A4 Antimicrobial amorphous compositions
11/19/2008EP1791863A4 Truncated lhrh formulations
11/19/2008EP1545607B1 Allergy vaccines
11/19/2008EP1513553B1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
11/19/2008EP1472288B1 Viral cd30 polypeptide
11/19/2008EP1453539B1 Immunotherapeutic methods and systems
11/19/2008EP1377667B1 Fusion proteins for specific treatment of cancer and auto-immune diseases
11/19/2008EP1373510B1 Mutant allergens
11/19/2008EP1372650B1 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
11/19/2008EP1358213B1 Humanized antibodies that recognize beta amyloid peptide
11/19/2008EP1307226B1 Vitronectin receptor antagonist pharmaceuticals
11/19/2008EP1301146A4 Artificial vascular grafts, and methods of producing and using same
11/19/2008EP1300158B9 Pharmaceutical compositions for angiogenic therapy
11/19/2008EP1294910B1 Protein glycosylation modification in pichia pastoris
11/19/2008EP1284741B1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
1 ... 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 ... 3163